Unique ID issued by UMIN | UMIN000001173 |
---|---|
Receipt number | R000001413 |
Scientific Title | Clinical trial to investigate the effect of long-term intake of tomato juice on atherosclelosis |
Date of disclosure of the study information | 2008/06/08 |
Last modified on | 2012/08/23 17:11:53 |
Clinical trial to investigate the effect of long-term intake of tomato juice on atherosclelosis
Clinical trial of long-term intake of tomato juice
Clinical trial to investigate the effect of long-term intake of tomato juice on atherosclelosis
Clinical trial of long-term intake of tomato juice
Japan |
Metabolic symdrome
Cardiology | Endocrinology and Metabolism |
Others
NO
To investigate the effect of long-term intake of tomato juice on atherosclelosis
Efficacy
Exploratory
Pragmatic
Phase II
Parameters of atherosclerosis (flow-mediated dilatation(FMD), blood endothelial progenitor cells (CD34/45/133/VEGFR), oxidized-LDL, inflammatory cytokines, highly-reactive CRP)
1) Serum total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol
2) FBS, HbA1c
3) Blood pressure, body weight, body fat parcentage, waist, BMI
4) Biomarkers; serum carotenoids, urine 8-OHdG, isoprostane, PAI-1, TNF-alfa, adiponectin
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Food |
Long-term intake of tomato juice with lycopene
Long-term intake of tomato serum juice without lycopene
50 | years-old | <= |
Not applicable |
Male and Female
1) Is over 50 years old and meets at least one of the followings; Serum triglycerides >= 150mg/dl and/or serum HDL-cholesterol< 40mg/dl, Systolic blood pressure >= 130mmHg and/or diastolic blood pressure >= 85mmHg, FBS >= 110mg/dl and/or BS >= 140mg/dl and/or HbA1c >= 5.8%
2) To whom follow up will be possible in out-patient clinic or in other appropriate ways for 9 months
3) No alterations will be required for the medication for hypertension, lipid disorder and/or diabetes mellitus in the study period
1) Has a history of malignant diseases and/or present malignant diseases
2) To whom pharmaceutical agents should be considered for hypertension, lipid disorder and/or diabetes mellitus
3) Has a overt systemic disease
4) Has a history of allergy to tomato
5) Has a history of cardiovascular events (cerebrovascular diseases, ischemic heart disease), has been receiving anti-platelet agents, anti-coagrants
6) Is a participant in other clinical trial
7) Is not appropriate in the investigators' opinion
40
1st name | |
Middle name | |
Last name | Masashi Akaike |
Tokushima University Hospital
Department of Cardiovascular Medicine
2-50-1 Kuramoto-cho, Tokushima
088-633-7851
1st name | |
Middle name | |
Last name | Chiho Sato |
Tokushima University Hospital
Clinical Trial Center for Developmental Therapeutics
2-50-1 Kuramoto-cho, Tokushima
088-633-9294
awachiken@clin.med.tokushima-u.ac.jp
Tokushima University Hospital
Food Company
Profit organization
Japan
NO
2008 | Year | 06 | Month | 08 | Day |
Unpublished
Completed
2008 | Year | 05 | Month | 01 | Day |
2008 | Year | 06 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2008 | Year | 06 | Month | 04 | Day |
2012 | Year | 08 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001413